FDG PET in Prostate Cancer
Author:
- 1 April 2009
- journal article
- review article
- Published by Elsevier in PET Clinics
- Vol. 4 (2) , 155-161
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- [F-18]-fluorodeoxyglucose PET-CT of the normal prostate glandAnnals of Nuclear Medicine, 2008
- Novel Tracers and Their Development for the Imaging of Metastatic Prostate CancerJournal of Nuclear Medicine, 2008
- Relationship Between Cancer Type and Impact of PET and PET/CT on Intended Management: Findings of the National Oncologic PET RegistryJournal of Nuclear Medicine, 2008
- Causes and Consequences of Increased Glucose Metabolism of CancersJournal of Nuclear Medicine, 2008
- Introduction: FIGURE 1.Journal of Nuclear Medicine, 2008
- Effect of hypoxia on the uptake of [methyl-3H]choline, [1-14C] acetate and [18F]FDG in cultured prostate cancer cellsNuclear Medicine and Biology, 2006
- Technische Grenzen des PET/CT mit 18FDG beim Adenokarzinom der ProstataAktuelle Urologie, 2006
- The Hallmarks of CancerCell, 2000
- Positron emission tomography with 18 fluorine‐labelled deoxyglucose: utility in localized and advanced prostate cancerBJU International, 1999
- Detection of bony metastases of androgen-independent prostate cancer by PET-FDGNuclear Medicine and Biology, 1996